ASP3026 is a novel and selective anaplastic lymphoma kinase (ALK) inhibitor that shows potent anti-tumor activities. ASP3026 also shows potential efficacy for non-small cell lung cancer (NSCLC) and is expected to improve the therapeutic outcomes of patie
Molecular Weight:
580.74
CAS Number:
[1097917-15-1]
* VAT and and shipping costs not included. Errors and price changes excepted